1. Home
  2. WVE vs DK Comparison

WVE vs DK Comparison

Compare WVE & DK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • DK
  • Stock Information
  • Founded
  • WVE 2012
  • DK 2001
  • Country
  • WVE Singapore
  • DK United States
  • Employees
  • WVE N/A
  • DK N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • DK Integrated oil Companies
  • Sector
  • WVE Health Care
  • DK Energy
  • Exchange
  • WVE Nasdaq
  • DK Nasdaq
  • Market Cap
  • WVE 915.6M
  • DK 1.0B
  • IPO Year
  • WVE 2015
  • DK 2006
  • Fundamental
  • Price
  • WVE $8.40
  • DK $22.69
  • Analyst Decision
  • WVE Strong Buy
  • DK Hold
  • Analyst Count
  • WVE 14
  • DK 13
  • Target Price
  • WVE $19.86
  • DK $20.60
  • AVG Volume (30 Days)
  • WVE 1.6M
  • DK 1.8M
  • Earning Date
  • WVE 07-30-2025
  • DK 08-06-2025
  • Dividend Yield
  • WVE N/A
  • DK 4.51%
  • EPS Growth
  • WVE N/A
  • DK N/A
  • EPS
  • WVE N/A
  • DK N/A
  • Revenue
  • WVE $104,939,000.00
  • DK $11,366,100,000.00
  • Revenue This Year
  • WVE N/A
  • DK N/A
  • Revenue Next Year
  • WVE $4.90
  • DK N/A
  • P/E Ratio
  • WVE N/A
  • DK N/A
  • Revenue Growth
  • WVE N/A
  • DK N/A
  • 52 Week Low
  • WVE $5.04
  • DK $11.03
  • 52 Week High
  • WVE $16.74
  • DK $27.07
  • Technical
  • Relative Strength Index (RSI)
  • WVE 63.68
  • DK 46.09
  • Support Level
  • WVE $7.69
  • DK $24.38
  • Resistance Level
  • WVE $8.70
  • DK $26.89
  • Average True Range (ATR)
  • WVE 0.53
  • DK 1.03
  • MACD
  • WVE 0.07
  • DK -0.46
  • Stochastic Oscillator
  • WVE 82.63
  • DK 10.25

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

Share on Social Networks: